Third Rock Ventures IV L.P. 13D and 13G filings for Fulcrum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-02-05 4:33 pm Purchase | 2019-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | Third Rock Ventures IV L.P. | 2,343,154 10.000% | 2,343,154 (New Position) | Filing |